Also trades as: OBMP (OTC) · $vol 0M
THER OTC
Theralink Technologies, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -95.2%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$607K
+6.8% ▲
Gross Profit
$481K
+40.1% ▲
Operating Income
-$9M
+22.9% ▲
Net Income
-$31M
-142.4% ▼
EPS (Diluted)
$-0.01
-127.3% ▼
EBITDA
-$9M
+23.7% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $0 | $181K | $506K | $568K | $607K |
| YoY Growth | +0.0% | +0.0% | +179.0% | +12.3% | +6.8% |
| Cost of Revenue | $0 | $53K | $117K | $225K | $126K |
| Gross Profit | $0 | $129K | $388K | $343K | $481K |
| Gross Margin | — | 71.0% | 76.8% | 60.4% | 79.2% |
| R&D Expenses | $167K | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2M | $3M | $6M | $12M | $9M |
| Operating Expenses | $2M | $3M | $6M | $12M | $9M |
| Operating Income | -$2M | -$3M | -$6M | -$12M | -$9M |
| Operating Margin | — | -1852.2% | -1100.9% | -2049.6% | -1479.8% |
| Interest Expense | $2M | $31K | $121K | $1M | $17M |
| Income Before Tax | -$9M | -$3M | -$5M | -$13M | -$31M |
| Tax Expense | $2M | $41K | $121K | $7K | $17M |
| Net Income | -$11M | -$3M | -$6M | -$13M | -$31M |
| Net Margin | — | -1772.1% | -1106.2% | -2245.0% | -5093.6% |
| EPS (Diluted) | $-22.63 | $-0.00 | $-0.00 | $-0.00 | $-0.01 |
| EBITDA | -$2M | -$3M | -$5M | -$11M | -$9M |
| Shares Outstanding | 494843 | 2.56B | 5.37B | 5.88B | 6.15B |